ProgStar Research Group

Stargardt Disease Study Sponsored by FFB


Study News

ProgStar at ARVO 2017

The ProgStar studies will be discussed during the 2017 annual meeting of the Association for Research in Vision and Opthalmology Read More…

Stargardt Disease

Stargardt Diseased Eye

Stargardt Disease (STGD) is the most prevalent form of juvenile-onset macular dystrophy, predominantly due to gene mutations in an autosomal Read More…



On this page you will find a list of current ProgStar publications as well as previous publications relevant to STGD by current ProgStar study investigators. Read More …

About the Study

Study Worker

Sponsored by the Foundation Fighting Blindness, the Natural History of the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) studies Read More…

Progstar's Mission

  • To determine the best outcome measures to accelerate evaluation of emerging treatments.
  • To better understand disease progression for selecting future clinical trial participants.
  • To identify potential participants for forthcoming clinical trials.
  • To establish technology, trial sites, Reading Center, and patient cohorts.